We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Mass Spectrometry Imaging Used to Process Biologic “Big Data”

By LabMedica International staff writers
Posted on 01 Dec 2014
Print article
The vast amounts of data that are generated by the latest scientific instruments are leading to significant scientific discoveries, but only when scientists can effectively process that data. Big data represents both an opportunity and a challenge for scientists. This is especially the case for analytic scientists studying biologic materials using a fairly new technique known as mass spectrometry imaging (MSI). Help has arrived from a recent project, however, called Computis, which has a range of new tools for effectively processing MSI data.

MSI is a form of mass spectrometry (MS) that enables both spatial and mass spectrometric analysis by measuring the masses of compounds at specific locations on the surface of a solid sample. MSI can, therefore, construct a visual image of its chemical composition. Various MSI techniques are available, including matrix-assisted laser desorption/ionization (MALDI), secondary ion MS (SIMS) and desorption electrospray ionization (DESI), but they all generate huge amounts of data.

Although software tools are available for processing this information, they tend to be produced by the manufacturers of the MSI instruments and therefore each uses diverse data formats, making it difficult to combine and process data generated by different instruments. Computis was set up by the European Commission in 2006 to overcome this hurdle by developing a new generation of flexible and efficient tools for processing any MSI data. It involved academic and industrial teams from across Europe, including the French Atomic Energy Commission and the Swiss pharmaceutical giant Novartis (Basel, Switzerland). The project was completed in 2010 and the main outputs have now been described November 2014 in an article in the European Journal of Mass Spectrometry (EJMS).

The project members rapidly figured out that their first task should be to develop a common format for MSI data that all the other data formats could be converted into, which led to the imzML data format. This format divides MSI data into two separate files: the mass data are stored in a binary file to ensure proficient storage, while metadata such as instrumental parameters and sample details are stored in an XML file. The members also developed several tools for translating MSI data in other formats into the imzML format.

The project then developed several tools specially designed to work with the imzML format. This included two tools for processing and displaying MSI data, Data Cube Explorer and SpectViewer, and a tool called EasyReg2D for incorporating MSI data with image data from other analytic instruments, including microscopes. Furthermore, the researchers adapted an existing MSI processing tool known as BioMap to work with data in the imzML format.

According to the investigators, this project has been successful in greatly expanding the tools available for processing MSI data, helping to ensure big data becomes an opportunity for scientists instead of remaining a challenge.

Related Links:

Novartis


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.